Clinical trial
Effects of ELDOA in Patients With Upper Cross Syndrome
NCT06564077 is registered in ClinicalTrials.gov with Riphah International University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of ELDOA in Patients With Upper Cross Syndrome
- Lead sponsor
- Riphah International University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 20, 2024
- Completion date
- January 10, 2025
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.